|
1
|
Englund M, Guermazi A, Gale D, Hunter DJ,
Aliabadi P, Clancy M and Felson DT: Incidental meniscal findings on
knee MRI in middle-aged and elderly persons. N Engl J Med.
359:1108–1115. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hunter DJ: Osteoarthritis. Best Pract Res
Clin Rheumatol. 25:801–814. 2011. View Article : Google Scholar
|
|
3
|
Radin EL and Rose RM: Role of subchondral
bone in the initiation and progression of cartilage damage. Clin
Orthop Relat Res. 213:34–40. 1986.PubMed/NCBI
|
|
4
|
Orth P, Cucchiarini M, Kaul G, Ong MF,
Gräber S, Kohn DM and Madry H: Temporal and spatial migration
pattern of the subchondral bone plate in a rabbit osteochondral
defect model. Osteoarthritis Cartilage. 20:1161–1169. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bünger MH, Birkbak M, Pedersen JS, et al:
Effect of bisphosphonate treatment on subchondral bone
nanostructure in the dunkin hartley guinea pig model of
osteoarthritis studied by scanning small-angle X-ray scattering.
Bone. 50(S1): S1172012. View Article : Google Scholar
|
|
6
|
Hudelmaier M, Wirth W, Nevitt M, et al:
Longitudinal rates of change in subchondral bone size in healthy
knees and knees with radiographic osteoarthritis. Osteoarthritis
Cartilage. 21:S2422013. View Article : Google Scholar
|
|
7
|
Boyce BF and Xing L: Functions of
RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem
Biophys. 473:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Trouvin AP and Goëb V: Receptor activator
of nuclear factor-κB ligand and osteoprotegerin: Maintaining the
balance to prevent bone loss. Clin Interv Aging. 5:345–354.
2010.
|
|
9
|
Tanaka H, Mine T, Ogasa H, Taguchi T and
Liang CT: Expression of RANKL/OPG during bone remodeling in vivo.
Biochem Biophys Res Commun. 411:690–694. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hawkey C, Laine L, Simon T, Beaulieu A,
Maldonado-Cocco J, Acevedo E, Shahane A, Quan H, Bolognese J and
Mortensen E: Comparison of the effect of rofecoxib (a
cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the
gastroduodenal mucosa of patients with osteoarthritis: a
randomized, double-blind, placebo-controlled trial. The Rofecoxib
Osteoarthritis Endoscopy Multinational Study Group. Arthritis
Rheum. 43:370–377. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng C, Ye H, Xu X and Liu XX:
Computational pharmacology study of tougu xiaotong granule in
preventing and treating knee osteoarthritis. Chin J Integr Med.
15:371–376. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin MN and Liu XX: Tougu Xiaotong
decoction for treating 30 cases of osteoarthritis of the knee.
Fujian J Tradit Chin Med. 36:15–16. 2005.In Chinese.
|
|
13
|
Li XH, Wu MX, Ye HZ, Chen WL, Lin JM,
Zheng LP and Liu XX: Experimental study on the suppression of
sodium nitroprussiate-induced chondrocyte apoptosis by Tougu
Xiaotong Capsule (透骨消痛胶囊)-containing serum. Chin J Integr Med.
17:436–443. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu ZL, Li XH, Wu GW, Ye HZ, WU MX and Liu
XX: Effect of drug-containing serum of Tougu Xiaotong Capsule to
apoptotic pathway of chondrocyte mitochondria. Chin J Tradit Chin
Med. 26:343–346. 2011.
|
|
15
|
Li X, Lang W, Ye H, Yu F, Li H, Chen J,
Cai L, Chen W, Lin R, Huang Y, et al: Tougu Xiaotong capsule
inhibits the tidemark replication and cartilage degradation of
papain-induced osteoarthritis by the regulation of chondrocyte
autophagy. Int J Mol Med. 31:1349–1356. 2013.PubMed/NCBI
|
|
16
|
Ye HZ, Li XH, Chen JS, Zheng CS, Yang JP,
Wong XP, Zeng ZP, Zheng Z and Liu XX: Study on the effect of Tougu
Xiaotong capsule medicated serum on the expression of cyclin D1
mRNA in chondrocytes. J Tradit Chin Orthopedic Traumatol. 24:3–7.
2012.In Chinese.
|
|
17
|
Huang YM, Chen WL, Liu XX, Huang MY, Lin
RH, Li Min, Xiao CY and Wu GW: Histochemical study of
osteoarthritis treated by Tougu Xiaotong granule. Chin J Tradit Med
Traumatol Orthop. 19:1–3. 2011.In Chinese.
|
|
18
|
Liu BL, Zou JL, Liang GQ, Liu XX, Li XH
and Wu GW: Regulatory effects of Tougu Xiaotong granule on
wnt/β-catenin signal pathway of articular chondrocytes. Chin J
Tissue Eng Res. 15:8574–8578. 2011.In Chinese.
|
|
19
|
Liu BL, Liang GQ, Liu XX, Wu GW and Li XH:
Expression of cyclooxygenase-2 and inducible nitric oxide synthase
in primary knee osteoarthritis interfered by Tougu Xiaotong
granules. Chin J Tissue Eng Res Clinic Rehabilit. 15:2034–2037.
2011.In Chinese.
|
|
20
|
Chen Y, Xiao XJ, Bao XP, et al: Analgesia
and anti-inflammatory effects of Tougu Xiaotong prescription. China
J Chin Med. 28:1675–1676. 2013.In Chinese.
|
|
21
|
Huang YM, Chen WL, Lin RH, Huang MY, Li
ZF, Liao NS and Liu XX: Tougu Xiaotong capsule promotes the
proliferation and differentiation of osteoblasts. Chinese J Tissue
Eng Res. 17:5923–5928. 2013.In Chinese.
|
|
22
|
Guidance Suggestions for the Care and Use
of Laboratory Animals. The Ministry of Science and Technology of
the People's Republic of China; Beijing, China: pp. 1–5. 2006, In
Chinese.
|
|
23
|
Liu XX, Li XH and Zhou JT: Experimental
study on replicating knee osteoarthritis by modified Hulth's
modeling method. Zhongguo Zhong Xi Yi Jie He Za Zhi. 25:1004–1008.
2005.In Chinese.
|
|
24
|
Kuettner KE and Cole AA: Cartilage
degeneration in different human joints. Osteoarthritis Cartilage.
13:93–103. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cox LG, van Donkelaar CC, van Rietbergen
B, Emans PJ and Ito K: Decreased bone tissue mineralization can
partly explain subchondral sclerosis observed in osteoarthritis.
Bone. 50:1152–1161. 2013. View Article : Google Scholar
|
|
26
|
Zhu S, Chen K, Lan Y, Zhang N, Jiang R and
Hu J: Alendronate protects against articular cartilage erosion by
inhibiting subchondral bone loss in ovariectomized rats. Bone.
53:340–349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kearns AE, Khosla S and Kostenuik PJ:
Receptor activator of nuclear factor kappaB ligand and
osteoprotegerin regulation of bone remodeling in health and
disease. Endocr Rev. 29:155–192. 2008. View Article : Google Scholar
|
|
28
|
Whyte MP, Obrecht SE, Finnegan PM, Jones
JL, Podgornik MN, McAlister WH and Mumm S: Osteoprotegerin
deficiency and Juvenile Paget's disease. N Engl Med. 347:175–184.
2002. View Article : Google Scholar
|
|
29
|
Trouvin AP and Goëb V: Receptor activator
of nuclear factor-κB ligand and osteoprotegerin: Maintaining the
balance to prevent bone loss. Clin Interv Aging. 5:345–354.
2010.
|
|
30
|
Brzóska MM and Rogalska J: Protective
effect of zinc supplementation against cadmium-induced oxidative
stress and the RANK/RANKL/OPG system imbalance in the bone tissue
of rats. Toxicol Appl Pharmacol. 272:208–220. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Maddi A, Hai H, Ong ST, Sharp L, Harris M
and Meghji S: Long wave ultrasound may enhance bone regeneration by
altering OPG/RANKL ratio in human osteoblast-like Cells. Bone.
39:283–288. 2006. View Article : Google Scholar : PubMed/NCBI
|
